Illumina, Inc. ILMN

270.00 (3.90) (1.42%) as of 25 Sep
Market cap
$41.3B
P/E
50.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Illumina, Inc. (ILMN) Operating margin

Illumina, Inc.'s operating margin over the twelve months to 30 June 2026 was 19.7%, up 1.1 percentage points from fiscal 2025 (18.6%). Over the past ten years it has ranged from −91.2% (fiscal 2022) to 27.8% (fiscal 2019); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 18.6% 37.63
FY2024 −19.1% 4.68
FY2023 −23.7% 67.43
FY2022 −91.2% (88.44)
FY2021 −2.72% (20.63)
FY2020 17.9% (9.89)
FY2019 27.8% 1.31
FY2018 26.5% 4.47
FY2017 22.0% (2.46)
FY2016 24.5% (3.13)

Quarterly

Period Operating margin Change (points)
Jun 2026 21.1% 1.98
Mar 2026 19.2% 1.73
Dec 2025 17.4% (3.51)
Sep 2025 20.9% 0.73
42 more quarters

Against its own ten years

Low −91.2% High 27.8%
Ten-year median 18.6%
Current reading's percentile 55

Operating margin against peers

Company Operating margin
IDXX IDEXX Laboratories, Inc. compare 32.0%
MTD Mettler-Toledo International, Inc. compare 28.4%
A Agilent Technologies, Inc. compare 22.2%
ILMN Illumina, Inc. 19.7%
DGX Quest Diagnostics Incorporated compare 14.1%
IQV IQVIA Holdings Inc. compare 13.0%
WAT Waters Corporation compare 7.10%
NTRA Natera, Inc. compare −10.7%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on ILMN